在生育友好消息频传之际,专注于生育健康全产业链的辅助生殖IVD第一股贝康医疗发布2024年度成绩单,表现亮眼。公司全年实现收入近3亿元,同比激增44%,标志着其国际化全产业链战略部署初见成效,有望成长为全球辅助生育领域最具创新力的企业。面对生育难,育儿贵等一系列问题,国内辅助生殖服务全面纳入医保体系,育儿补贴相关政策也在加速落地。与此同时,美国白宫签署行政令强化生育医疗保障,明确要求商业保险计划...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.